Apogee Therapeutics, Inc. APGE Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $451.8M+243% | $131.55M+21.9% | $107.91M-13.1% | $124.19M+16.2% | $106.92M-24.6% | ||
| $608.09M+1.6% | $598.64M+42.7% | $419.38M+10.0% | $381.23M-6.2% | $406.41M+7.3% | ||
| $1.07B+44.8% | $741.36M+37.3% | $540.1M+4.6% | $516.12M-1.0% | $521.53M-1.5% | ||
| $5.28M-7.2% | $5.69M-5.7% | $6.03M-6.3% | $6.44M+13.4% | $5.68M+190% | ||
| $1.29B+38.0% | $937.13M+49.7% | $626.16M-4.8% | $657.77M-7.9% | $714.16M-5.3% | ||
| $1.24M+1.3% | $1.22M+225% | $376K-93.4% | $5.68M+132% | $2.45M+128% | ||
| $32.95M+18.1% | $27.91M-18.0% | $34.05M+7.9% | $31.55M-4.3% | $32.96M+15.4% | ||
| $37.86M+13.9% | $33.25M-16.5% | $39.82M+3.8% | $38.37M-6.0% | $40.8M+9.8% | ||
| $1K0.0% | $1K0.0% | $1K0.0% | $1K0.0% | $1K0.0% | ||
| -$635.87M-13.2% | -$561.76M-14.1% | -$492.37M-15.2% | -$427.35M-18.3% | -$361.26M-18.1% | ||
| $1.29B+38.0% | $937.13M+49.7% | $626.16M-4.8% | $657.77M-7.9% | $714.16M-5.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Apogee Therapeutics, Inc.'s total assets?
- Apogee Therapeutics, Inc. (APGE) holds $1.3B in total assets, up 81.1% year over year.
- How much cash does Apogee Therapeutics, Inc. have?
- Apogee Therapeutics, Inc. holds $451.8M in cash and equivalents.
- Can Apogee Therapeutics, Inc. cover its short-term obligations?
- Its current ratio is 32.59 — current assets exceed current liabilities.
- Where does Apogee Therapeutics, Inc.'s balance sheet data come from?
- Every line is extracted from Apogee Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.